211 related articles for article (PubMed ID: 31520600)
1. Novel anti-angiogenic PEDF-derived small peptides mitigate choroidal neovascularization.
Sheibani N; Wang S; Darjatmoko SR; Fisk DL; Shahi PK; Pattnaik BR; Sorenson CM; Bhowmick R; Volpert OV; Albert DM; Melgar-Asensio I; Henkin J
Exp Eye Res; 2019 Nov; 188():107798. PubMed ID: 31520600
[TBL] [Abstract][Full Text] [Related]
2. Type I pig collagen enhances the efficacy of PEDF 34-mer peptide in a mouse model of laser-induced choroidal neovascularization.
Kim HW; Roh KH; Kim SW; Park SJ; Lim NY; Jung H; Choi IW; Park S
Graefes Arch Clin Exp Ophthalmol; 2019 Aug; 257(8):1709-1717. PubMed ID: 31222405
[TBL] [Abstract][Full Text] [Related]
3. Effects of human recombinant PEDF protein and PEDF-derived peptide 34-mer on choroidal neovascularization.
Amaral J; Becerra SP
Invest Ophthalmol Vis Sci; 2010 Mar; 51(3):1318-26. PubMed ID: 19850839
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of retinal neovascularization by a PEDF-derived nonapeptide in newborn mice subjected to oxygen-induced ischemic retinopathy.
Sheibani N; Zaitoun IS; Wang S; Darjatmoko SR; Suscha A; Song YS; Sorenson CM; Shifrin V; Albert DM; Melgar-Asensio I; Kandela I; Henkin J
Exp Eye Res; 2020 Jun; 195():108030. PubMed ID: 32272114
[TBL] [Abstract][Full Text] [Related]
5. Suppression of choroidal neovascularization by vasohibin-1, a vascular endothelium-derived angiogenic inhibitor.
Wakusawa R; Abe T; Sato H; Sonoda H; Sato M; Mitsuda Y; Takakura T; Fukushima T; Onami H; Nagai N; Ishikawa Y; Nishida K; Sato Y
Invest Ophthalmol Vis Sci; 2011 May; 52(6):3272-80. PubMed ID: 21345982
[TBL] [Abstract][Full Text] [Related]
6. Pigment Epithelium-Derived Factor as a Possible Treatment Agent for Choroidal Neovascularization.
Xi L
Oxid Med Cell Longev; 2020; 2020():8941057. PubMed ID: 32215180
[TBL] [Abstract][Full Text] [Related]
7. Alternate serotype adenovector provides long-term therapeutic gene expression in the eye.
Hamilton MM; Byrnes GA; Gall JG; Brough DE; King CR; Wei LL
Mol Vis; 2008; 14():2535-46. PubMed ID: 19122827
[TBL] [Abstract][Full Text] [Related]
8. Targeting therapy of choroidal neovascularization by use of polypeptide- and PEDF-loaded immunoliposomes under ultrasound exposure.
Li T; Zhang M; Han Y; Zhang H; Xu L; Xiang Y
J Huazhong Univ Sci Technolog Med Sci; 2010 Dec; 30(6):798-803. PubMed ID: 21181375
[TBL] [Abstract][Full Text] [Related]
9. A short peptide derived from pigment epithelial-derived factor exhibits an angioinhibitory effect.
Ho TC; Yeh SI; Chen SL; Chu TW; Tsao YP
BMC Ophthalmol; 2022 Feb; 22(1):88. PubMed ID: 35193548
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of pigment epithelium-derived factor inhibits retinal inflammation and neovascularization.
Park K; Jin J; Hu Y; Zhou K; Ma JX
Am J Pathol; 2011 Feb; 178(2):688-98. PubMed ID: 21281801
[TBL] [Abstract][Full Text] [Related]
11. Propranolol Attenuates Proangiogenic Activity of Mononuclear Phagocytes: Implication in Choroidal Neovascularization.
Omri S; Tahiri H; Pierre WC; Desjarlais M; Lahaie I; Loiselle SE; Rezende F; Lodygensky G; Hebert TE; Ong H; Chemtob S
Invest Ophthalmol Vis Sci; 2019 Nov; 60(14):4632-4642. PubMed ID: 31682714
[TBL] [Abstract][Full Text] [Related]
12. Expression of pigment epithelium-derived factor in normal adult rat eye and experimental choroidal neovascularization.
Ogata N; Wada M; Otsuji T; Jo N; Tombran-Tink J; Matsumura M
Invest Ophthalmol Vis Sci; 2002 Apr; 43(4):1168-75. PubMed ID: 11923262
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Topical Pigment Epithelium-Derived Factor (PEDF) with Topical Bevacizumab for Accelerating the Regression of Corneal Neovascularization in an Experimental Model of Rabbit Corneal Angiogenesis.
Mahmoudzadeh R; Heidari-Keshel S; Mehrpour M; Asadi Amoli F; Aghajanpour L; Lashay A
Ocul Immunol Inflamm; 2021 Nov; 29(7-8):1471-1477. PubMed ID: 32407187
[No Abstract] [Full Text] [Related]
14. Pigment epithelium-derived factor is deficient in the vitreous of patients with choroidal neovascularization due to age-related macular degeneration.
Holekamp NM; Bouck N; Volpert O
Am J Ophthalmol; 2002 Aug; 134(2):220-7. PubMed ID: 12140029
[TBL] [Abstract][Full Text] [Related]
15. Ultrasound-mediated microbubble delivery of pigment epithelium-derived factor gene into retina inhibits choroidal neovascularization.
Zhou XY; Liao Q; Pu YM; Tang YQ; Gong X; Li J; Xu Y; Wang ZG
Chin Med J (Engl); 2009 Nov; 122(22):2711-7. PubMed ID: 19951601
[TBL] [Abstract][Full Text] [Related]
16. [An experimental study on choroidal neovascularization inhibited by adenoviral vectored pigment epithelium-derived factor].
Yan H; Wang Y; Cui J; Yu YP
Zhonghua Yan Ke Za Zhi; 2008 May; 44(5):442-7. PubMed ID: 18953901
[TBL] [Abstract][Full Text] [Related]
17. Pigment epithelium-derived factor suppresses ischemia-induced retinal neovascularization and VEGF-induced migration and growth.
Duh EJ; Yang HS; Suzuma I; Miyagi M; Youngman E; Mori K; Katai M; Yan L; Suzuma K; West K; Davarya S; Tong P; Gehlbach P; Pearlman J; Crabb JW; Aiello LP; Campochiaro PA; Zack DJ
Invest Ophthalmol Vis Sci; 2002 Mar; 43(3):821-9. PubMed ID: 11867604
[TBL] [Abstract][Full Text] [Related]
18. AAV-mediated gene transfer of pigment epithelium-derived factor inhibits choroidal neovascularization.
Mori K; Gehlbach P; Yamamoto S; Duh E; Zack DJ; Li Q; Berns KI; Raisler BJ; Hauswirth WW; Campochiaro PA
Invest Ophthalmol Vis Sci; 2002 Jun; 43(6):1994-2000. PubMed ID: 12037010
[TBL] [Abstract][Full Text] [Related]
19. Polyethylene glycol-modified pigment epithelial-derived factor: new prospects for treatment of retinal neovascularization.
Bai YJ; Huang LZ; Xu XL; Du W; Zhou AY; Yu WZ; Li XX
J Pharmacol Exp Ther; 2012 Jul; 342(1):131-9. PubMed ID: 22495066
[TBL] [Abstract][Full Text] [Related]
20. Growth suppression of cervical carcinoma by pigment epithelium-derived factor via anti-angiogenesis.
Yang J; Chen S; Huang X; Han J; Wang Q; Shi D; Cheng R; Gao G; Yang X
Cancer Biol Ther; 2010 Jun; 9(12):967-74. PubMed ID: 20364117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
